Parse Biosciences is a technology company that specializes in developing innovative solutions for single-cell sequencing. Their platforms aim to make single-cell analysis more accessible, scalable, and cost-effective, enabling researchers to unlock new insights into complex biological systems.

Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.

Horizon Technology Finance

National Science Foundation

Sahsen Ventures

Bioeconomy Capital

Soleus Capital

Janus Henderson Investors

Logos Capital

Marshall Wace

Saras Capital

Parse Biosciences

COM:PARSEBIOSCIENCES

Parse Biosciences

Analysis Not Available